Donate today. Give Ivy a chance to thrive.

Every gift—big or small—helps the groundbreaking biotech non-profit n-Lorem make Ivy the precision genetic treatment she needs.

A rare genetic race against time

Ivy is one of only three children known to have her specific, ultra-rare mutation of the GRIA2 glutamate receptor gene. At just 18 months old, she is already grappling with multiple features of GRIA2 neurodevelopmental disorder including epilepsy, cerebral vision impairment, and serious developmental delays.

Without intervention, this toxic mutation will continue to damage her brain cells, causing irreversible and widespread harm. We aren't just fighting a diagnosis, we are fighting to stop the clock before her brain begins losing the ability to re-root and re-grow.

Ivy’s only hope is a personalized Antisense Oligonucleotide (ASO) treatment. This ASO is designed to silence her harmful, mutated GRIA2 copy while allowing her healthy copy to function normally.

We have partnered with the n-Lorem Foundation, a world-renowned non-profit that has already successfully treated 50 patients with a spotless safety record. Their rigorous process can deliver this life-changing medicine to Ivy. Our fundraising goal is important! It supports n-Lorem’s work to create a treatment for Ivy.

Our Goal: Raise the necessary funds by March 2027 to begin clinical treatment before Ivy turns five, giving her the precision medicine she needs to thrive.

A precision treatment for Ivy

Campaign Progress

$0
raised of $0 goal
0%

Frequently Asked Questions